hdr isap 2019

Annual meeting 2021

 The ISAP 2021 meeting was held as a full day virtual conference in collaboration with EPASG on Friday, November 12 2021 - Saturday November 13 2021 as a online meeting.

Program

Friday November 12 2021
13.00-13.10         Welcome on behalf of EPASG
(CET)                     Markus Zeitlinger
 
13.10-13.15         A Themed Issue in Honour of Professor Hartmut Derendorf in ‘Antibiotics’
(CET)                     Francoise Van Bambeke
 
13.15-15.15          Session I: Tribute to Hartmut Derendorf (Ursula Theuretzbacher, William Couet, Markus
(CET)                      Zeitlinger)
Amparo de la Peña: Hartmut Derendorf: Scientific Impact and Personal Legacy
Teresa Dalla Costa: Microdialysis to investigate antimicrobials tissue penetration: lessons learned!!
Günther Hochhaus: Hartmut Derendorf’s impact beyond antimicrobial pharmacology
Jürgen Bulitta: Hartmut Derendorf’s impact on antimicrobial pharmacology over four decades and beyond
 
15.15-15.30          Coffee break
(CET)                                                      
 
15:30-17.00         Session II: Viral PK/PD (Cornelia Landersdorfer, Lena Friberg, Sebastian Wicha)
(CET)                     
Isabelle Bekeredjian-Ding: Regulatory decision making on COVID-19 vaccines
Ashley Brown: Nucleoside/Nucleotide Antiviral Therapy for the Treatment of COVID-19: It’s What’s on the Inside that Counts
Ryan Vargo: Enhancing Antiviral Drug Development through Translation and Quantitative Pharmacology
17.00-17.15         Coffee break        
(CET)
17.15-18.15         Young Investigator Session Part I (Francoise Van Bambeke, Alina Nussbaumer-Pröll)
(CET)
 
Saturday November 13 2021
8.30-9.40              Young Investigator Session Part II (Sandrine Marchand, Elisabet Nielsen)
(CET)
9.40-10:00           Coffee break        
(CET)
10:00-11.15         Session III: Combination therapy (Alexia Chauzy, Thomas Tängdén)
(CET)                     Cornelia Landersdorfer: PK/PD modelling as a tool to better understand drug-drug interactions in combinations
                             Stephen H. Gillespie: A fresh look on drug combinations in TB
11.15-12.00         Lunch break
(CET)
12.00-13.00         Pro/Con: Translating Preclinical Models to Clinical Outcomes (Jian Li, Zackery Bulman)
 (CET)                     Pro:        Sujata Bhavnani
                              Con:        John Turnidge
13.00-14.00         Pro/Con: To TDM or not to TDM? (Birgit Koch, Iris Minichmayr)
 (CET)                      Pro:        Angela Huttner
                               Con:        Bruce Dalton
14.00-14.15         Presentation of the Young Investigator Awards (Alina Nussbaumer-Pröll, Elisabet Nielsen)
(CET)               
      
Closing on behalf of ISAP
Sebastian Wicha
 

 group 1 2021

group 2 2021

 

 

Young Investigator session awards

As per the ISAP tradition, Young Investigators presented their research in the traditional Young Investigator session. The presentation topics ranged from pre-clinical, mechanistic PK-PD studies up to clinical applications of PK-PD. All research was presented very comprehensively and to the highest scientific standards.

The attendees voted the best three presentations who recieved the Young Investigator Awards 2021:

Winner:

Vincent Aranzana-Climent (Uppsala University, Sweden)

 Runner-ups:

Khalid Iqbal (University of Hamburg, Germany)                              Anselm Jorda (Medical University of Vienna, Austria)

 first winner 2021  second winners 2021